{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:06:25Z","timestamp":1789506385416,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajconline.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.amjcard.2017.06.040","type":"journal-article","created":{"date-parts":[[2017,7,21]],"date-time":"2017-07-21T04:18:52Z","timestamp":1500610732000},"page":"1055-1061","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Meta-Analysis of Randomized Trials of Intracoronary Versus Intravenous Glycoprotein IIb\/IIIa Inhibitors in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention"],"prefix":"10.1016","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4248-781X","authenticated-orcid":false,"given":"Ayman","family":"Elbadawi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9853-7591","authenticated-orcid":false,"given":"Islam Y.","family":"Elgendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Megaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2085-7293","authenticated-orcid":false,"given":"Le Dung","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erfan","family":"Alotaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gbolahan O.","family":"Ogunbayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basarat","family":"Baig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.S.","family":"Abuzaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwan","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremiah P.","family":"Depta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2017.06.040_bib0010","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s40119-016-0073-3","article-title":"Intracoronary eptifibatide during primary percutaneous coronary intervention in early versus late presenters with ST segment elevation myocardial infarction: a randomized trial","volume":"5","author":"Elbadawi","year":"2016","journal-title":"Cardiol Ther"},{"key":"10.1016\/j.amjcard.2017.06.040_bib0015","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0140-6736(11)61872-2","article-title":"Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a randomised trial","volume":"379","author":"Thiele","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2017.06.040_bib0020","doi-asserted-by":"crossref","first-page":"465","DOI":"10.5551\/jat.30965","article-title":"Comparison between the outcomes of intracoronary and intravenous administration of eptifibatide during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction","volume":"23","author":"Esfandi","year":"2016","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.amjcard.2017.06.040_bib0025","article-title":"Intracoronary versus Intravenous eptifibatide during percutaneous coronary intervention for acute ST-segment elevation myocardial infarction; a randomized controlled trial","author":"Sanati","year":"2016","journal-title":"Cardiovasc Interv Ther"},{"key":"10.1016\/j.amjcard.2017.06.040_bib0030","first-page":"517","article-title":"Effects of domestic tirofiban on coronary perfusion and clinical prognosis after acute interventional therapy for acute ST-elevation myocardial infarction in coronary arteries","volume":"35","author":"Yang Xinchun","year":"2007","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"10.1016\/j.amjcard.2017.06.040_bib0035","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.amjcard.2011.11.053","article-title":"Meta-analysis of randomized controlled trials comparing intracoronary and intravenous administration of glycoprotein IIb\/IIIa inhibitors in patients with ST-elevation myocardial infarction","volume":"109","author":"Wang","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2017.06.040_bib0040","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.amjcard.2011.10.016","article-title":"Meta-analysis of prospective randomized controlled trials comparing intracoronary versus intravenous abciximab in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention","volume":"109","author":"Shimada","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2017.06.040_bib0045","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/j.amjcard.2016.08.068","article-title":"Pooled analysis comparing the efficacy of intracoronary versus intravenous abciximab in smokers versus nonsmokers undergoing primary percutaneous coronary revascularization for acute ST-elevation myocardial infarction","volume":"118","author":"Piccolo","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2017.06.040_bib0050","first-page":"412","article-title":"Intracoronary versus intravenous abciximab bolus in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: a systematic review and meta-analysis","author":"Sakurai","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2017.06.040_bib0055","series-title":"Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine","author":"Mann","year":"2014"},{"key":"10.1016\/j.amjcard.2017.06.040_bib0060","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.amjcard.2017.06.040_bib0065","series-title":"Review Manager (RevMan) [Computer program]","year":"2014"},{"key":"10.1016\/j.amjcard.2017.06.040_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Softw"},{"key":"10.1016\/j.amjcard.2017.06.040_bib0075","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bmj.323.7303.42","article-title":"Assessing the quality of controlled clinical trials","volume":"323","author":"Juni","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.amjcard.2017.06.040_bib0080","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.amjcard.2017.06.040_bib0085","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses [journal article as teaching resource, deposited by John Flynn]","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.amjcard.2017.06.040_bib0090","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.atherosclerosis.2009.03.011","article-title":"Intracoronary versus intravenous abciximab administration in patients with ST-elevation myocardial infarction undergoing thrombus aspiration during primary percutaneous coronary intervention\u2014effects on soluble CD40 ligand concentrations","volume":"206","author":"Dominguez-Rodriguez","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.amjcard.2017.06.040_bib0095","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/ccd.20041","article-title":"Increase of myocardial salvage and left ventricular function recovery with intracoronary abciximab downstream of the coronary occlusion in patients with acute myocardial infarction treated with primary coronary intervention","volume":"62","author":"Bellandi","year":"2004","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2017.06.040_bib0100","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.amjcard.2010.01.006","volume":"105","author":"Bertrand","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2017.06.040_bib0105","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1161\/CIRCULATIONAHA.110.002741","article-title":"Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration clinical perspective","volume":"122","author":"Gu","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2017.06.040_bib0110","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1161\/CIRCULATIONAHA.107.747642","volume":"118","author":"Thiele","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2017.06.040_bib0115","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1540-8183.2010.00616.x","article-title":"Intracoronary compared to intravenous bolus abciximab during primary percutaneous coronary intervention in ST-segment Elevation Myocardial Infarction (STEMI) patients reduces 30-day mortality and target vessel revascularization: a randomized trial","volume":"24","author":"Iversen","year":"2011","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.amjcard.2017.06.040_bib0120","first-page":"132","article-title":"Comparison between intracoronary abciximab and intravenous eptifibatide administration during primary percutaneous coronary intervention of acute ST-segment elevation myocardial infarction","volume":"8","author":"Namazi","year":"2013","journal-title":"J Tehran Heart Cent"},{"key":"10.1016\/j.amjcard.2017.06.040_bib0125","doi-asserted-by":"crossref","first-page":"310","DOI":"10.5603\/CJ.2013.0077","article-title":"Intravenous versus intracoronary bolus of glycoprotein IIb\/IIIa inhibitor administration during primary percutaneous coronary intervention on long-term left ventricular systolic and diastolic function","volume":"20","author":"Pellicori","year":"2013","journal-title":"Cardiol J"},{"key":"10.1016\/j.amjcard.2017.06.040_bib0130","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2459\/JCM.0000000000000119","article-title":"Similar anti-inflammatory effects of intracoronary and intravenous Abciximab during primary percutaneous coronary intervention: a randomized study","volume":"16","author":"Secco","year":"2015","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"10.1016\/j.amjcard.2017.06.040_bib0135","series-title":"Improving outcome of STEMI PCI: Preliminary Results of Crystal AMI trial","author":"Dave","year":"2011"},{"key":"10.1016\/j.amjcard.2017.06.040_bib0140","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000333117","article-title":"Intracoronary compared to intravenous abciximab in patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention reduces mortality, target vessel revascularization and reinfarction after 1 year","volume":"120","author":"Iversen","year":"2011","journal-title":"Cardiology"},{"key":"10.1016\/j.amjcard.2017.06.040_bib0145","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.jacc.2013.06.014","article-title":"Intracoronary versus intravenous abciximab bolus in patients with ST-segment elevation myocardial infarction","volume":"62","author":"Desch","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2017.06.040_bib0150","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.amjcard.2016.11.036","article-title":"Meta-analysis of randomized trials on remote ischemic conditioning during primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction","volume":"119","author":"Elbadawi","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2017.06.040_bib0155","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1001\/jama.2012.421","article-title":"Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial","volume":"307","author":"Stone","year":"2012","journal-title":"JAMA"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914917311025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914917311025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T09:32:04Z","timestamp":1582536724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914917311025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0002914917311025"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2017.06.040","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meta-Analysis of Randomized Trials of Intracoronary Versus Intravenous Glycoprotein IIb\/IIIa Inhibitors in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2017.06.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}